eISSN: 1897-4252
ISSN: 1731-5530
Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
1/2020
vol. 17
 
Share:
Send email
Share:
abstract:
Original paper

Initial experience with the Perceval S sutureless aortic valve

Tatjana Raickovic
1
,
Igor Zivkovic
1
,
Tatjana Ragus
1
,
Slobodan Tomic
2
,
Petar Vukovic
1
,
Dusko Nezic
1
,
Miodrag Peric
1
,
Slobodan Micovic
1

  1. Department of Cardiac Surgery, Dedinje Cardiovascular Institute, Belgrade, Serbia
  2. Department of Cardiology, Dedinje Cardiovascular Institute, Belgrade, Serbia
Kardiochir Torakochir Pol 2020; 17 (1): 20-23
DOI: https://doi.org/10.5114/kitp.2020.94186
Online publish date: 2020/04/08
View full text Get citation
 
PlumX metrics:
Introduction
Surgical treatment of the aortic valve represents the gold standard, and thus aortic valve replacement (AVR) is one of the most commonly performed cardiac operations.

Aim
To evaluate the early outcome of aortic valve replacement with the Perceval S sutureless aortic bioprosthesis.

Material and methods
This was a retrospective analysis of 24 patients (mean age: 71 ±5 years), who underwent aortic valve replacement with a Perceval S valve. Concomitant coronary artery bypass grafting (CABG) was performed in 9 patients. Patients were evaluated preoperatively, at hospital discharge, and once during follow-up.

Results
A total of 15 of 24 patients underwent isolated sutureless aortic valve replacement (mean aortic cross-clamp time: 60 ±14 minutes; mean bypass time: 90 ±23 minutes). Coronary bypass grafting was performed in 9 patients (mean aortic cross-clamp time: 78 ±23 minutes; mean bypass time: 111 ±31 minutes). Hospital mortality was nil. Mean and peak transvalvular pressure gradients were 10 ±2 mm Hg and 21 ±3 mm Hg at follow-up, respectively. Moderate or severe aortic regurgitation did not develop in any patients during the follow-up period. No valve thrombosis, thromboembolic events, or structural valve deterioration were observed.

Conclusions
In our experience with sutureless aortic valve replacement, the surgical procedure is shown to be safe. The early haemodynamic performance seems favourable. By shortening the aortic cross-clamp and bypass times we can notice advantages, especially in high-risk patients. Minimally invasive access seems to be facilitated. Larger studies are needed to confirm our data and determine the long-term durability of the Perceval S sutureless bioprosthesis.

keywords:

sutureless valve, Perceval S bioprosthesis, aortic valve replacement
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.